Minimal supportive treatment in natalizumab-related PML in a MS patient

被引：4
|
作者：
Lalive, Patrice H. [1 ,2 ,3 ]
Bridel, Claire [1 ,2 ]
Ferfoglia, Ruxandra Iancu [1 ,2 ]
Kaiser, Laurent [3 ,4 ,5 ]
Du Pasquier, Renaud [6 ,7 ]
Barkhof, Frederik [8 ,9 ]
Haller, Sven [2 ,10 ]
机构：
[1] Univ Hosp Geneva, Dept Clin Neurosci, Div Neurol, Unit Neuroimmunol & Multiple Sclerosis, CH-1211 Geneva 4, Switzerland
[2] Univ Geneva, Fac Med, Geneva, Switzerland
[3] Univ Hosp Geneva, Dept Genet & Lab Med, Div Lab Med, CH-1211 Geneva 4, Switzerland
[4] Univ Hosp Geneva, Div Infect Dis, Lab Virol, CH-1211 Geneva 4, Switzerland
[5] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland
[6] CHU Vaudois, Dept Clin Neurosci, Div Neurol, CH-1011 Lausanne, Switzerland
[7] CHU Vaudois, Dept Med, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland
[8] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
[9] Vrije Univ Amsterdam, Med Ctr, IAC, Amsterdam, Netherlands
[10] Univ Hosp Geneva, Dept Imaging & Med Informat, CH-1211 Geneva 4, Switzerland
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2015年 / 86卷 / 03期
关键词：
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; MULTIPLE-SCLEROSIS;
D O I：
10.1136/jnnp-2014-308154
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：354 / U184
页数：2
相关论文
共 50 条
  • [41] Immunological markers for PML prediction in MS patients treatec with natalizumab
    Antoniol, Caroline
    Stankoff, Bruno
    FRONTIERS IN IMMUNOLOGY, 2015, 5
  • [42] Treatment of natalizumab-associated PML with filgrastim
    Stefoski, Dusan
    Balabanov, Roumen
    Waheed, Rasha
    Ko, Michael
    Koralnik, Igor J.
    Morales, Fabian Sierra
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (05): : 923 - 931
  • [43] Natalizumab Related PML: An Evolving Risk Stratification Paradigm
    Foley, John
    NEUROLOGY, 2013, 80
  • [44] Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?
    Scarpazza, Cristina
    Prosperini, Luca
    Mancinelli, Chiara R.
    De Rossi, Nicola
    Lugaresi, Alessandra
    Capobianco, Marco
    Moiola, Lucia
    Naldi, Paola
    Imberti, Luisa
    Gerevini, Simonetta
    Capra, Ruggero
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 378 : 233 - 237
  • [45] Brain susceptibility Changes in a patient with Natalizumab-Related progressive Multifocal Leukoencephalopathy: a Longitudinal Quantitative susceptibility Mapping and Relaxometry study
    Pontillo, Giuseppe
    Cocozza, Sirio
    Lanzillo, Roberta
    Borrelli, Pasquale
    De Rosa, Anna
    Morra, Vincenzo Brescia
    Tedeschi, Enrico
    Palma, Giuseppe
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [46] Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy
    Prosperini, Luca
    Scarpazza, Cristina
    Imberti, Luisa
    Cordioli, Cinzia
    De Rossi, Nicola
    Capra, Ruggero
    JOURNAL OF NEUROVIROLOGY, 2017, 23 (05) : 742 - 749
  • [47] Uncommon Infratentorial Localisation of PML in Natalizumab-Treated MS Patients
    Karageorgiou, Clementine E.
    Giannouli, Ermioni
    Emmanuel, Garifalia
    Athanasouli, Asimina
    Kargadou, Altani
    Tagaris, Georgios
    ANNALS OF NEUROLOGY, 2014, 76 : S109 - S110
  • [48] Outcome and survival of asymptomatic PML in natalizumab-treated MS patients
    Dong-Si, Tuan
    Richman, Sandra
    Wattjes, Mike P.
    Wenten, Made
    Gheuens, Sarah
    Philip, Jeffrey
    Datta, Shoibal
    McIninch, James
    Bozic, Carmen
    Bloomgren, Gary
    Richert, Nancy
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2014, 1 (10): : 755 - 764
  • [49] Chemokine-triggered migration into the CNS during MS and its modulation by treatment with natalizumab or during PML
    Marie, Deffner
    Schneider-Hohendorf, Tilman
    Ostkamp, Patrick
    Schumann, Eva
    Schulte-Mecklenbeck, Andreas
    Goelz, Susan
    Gross, Catharina C.
    Wiendl, Heinz
    Schwab, Nicholas
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 235 - 235
  • [50] Reduction of the risk of PML in natalizumab treated MS patients in Sweden: An effect of improved PML risk surveillance
    Kagstrom, Stina
    Falt, Anna
    Berglund, Anders
    Piehl, Fredrik
    Olsson, Tomas
    Lycke, Jan
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 50
12345